Orlando shooting sparks calls to end limits on gay men donating blood.
By Michelle Andrews, Kaiser Health News
33 percent of patients with HIV and lung cancer failed to receive any treatment for the cancer compared with 14 percent of those who weren’t infected.
By Helen Branswell, STAT
Rates of HIV infection among men who have sex with men are highest in six Southern states and the District of Columbia, according to a new analysis, conducted by researchers at Emory University.
By Andrew Joseph, STAT
Researchers from the Centers for Disease Control and Prevention estimated a person’s lifetime risk of HIV diagnosis by sex, ethnicity, sexual orientation, and state of residence.
By Corinne Segal
Today is the 258th day that Michael Broder has published a poem on HIV. The online collection, titled HIV Here & Now, is a yearlong project by Broder to publish one poem a day leading up to June 5,…
By Barbara Feder Ostrov, Kaiser Health News
Prudential Financial Inc., one of the nation’s largest life insurers, plans to announce this week that it will offer traditional individual policies to eligible people living with HIV.
By PBS NewsHour
NewsHour's John Carlos Frey reports in this updated segment on San Francisco's plan to zero out the number of new HIV infections. The city's public health officials, doctors, and activists have made huge strides battling the epidemic and are now…
More than 30 years after she identified one of the most pernicious viruses to infect humankind, Françoise Barré-Sinoussi, who shared the Nobel Prize in Physiology or Medicine for discovering HIV, is retiring. Barré-Sinoussi says even though a cure may never…
By Michelle Harven
After outrage from the public and even presidential candidates, Turing Pharmaceuticals has announced it will reduce the price of the drug whose cost had previously increased by more than 5,000 percent practically overnight.
The price of Darapim, a 62-year-old medical treatment used by AIDS patients, has increased by more than 5,000 percent after being acquired by pharmaceutical company Turing Pharmaceuticals for $55 million on August 10.
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.